JD Health International Inc. (BKK:JDHEAL19)
Thailand
· Delayed Price · Currency is THB 4.000
+0.080 (2.04%)
At close: Mar 9, 2026
JD Health International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 73,441 | 58,160 | 53,530 | 46,736 | 30,682 | Upgrade
|
| Revenue Growth (YoY) | 26.27% | 8.65% | 14.54% | 52.32% | 58.30% | Upgrade
|
| Cost of Revenue | 55,242 | 44,851 | 41,665 | 36,845 | 23,485 | Upgrade
|
| Gross Profit | 18,199 | 13,309 | 11,865 | 9,892 | 7,197 | Upgrade
|
| Selling, General & Admin | 12,624 | 10,499 | 9,938 | 8,871 | 7,670 | Upgrade
|
| Research & Development | 1,634 | 1,330 | 1,226 | 1,067 | 892.91 | Upgrade
|
| Operating Expenses | 14,401 | 12,146 | 11,234 | 10,037 | 8,601 | Upgrade
|
| Operating Income | 3,798 | 1,163 | 630.85 | -145.12 | -1,404 | Upgrade
|
| Interest Expense | -11.1 | -8.19 | -9.49 | -9.1 | -6 | Upgrade
|
| Interest & Investment Income | 1,538 | 1,961 | 1,949 | 864.27 | 457.57 | Upgrade
|
| Earnings From Equity Investments | -64.05 | -85.53 | -70.76 | -96.76 | -94.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 769.61 | 1,767 | 193.71 | 82.52 | 145.15 | Upgrade
|
| EBT Excluding Unusual Items | 6,030 | 4,797 | 2,693 | 695.81 | -901.49 | Upgrade
|
| Pretax Income | 6,030 | 4,797 | 2,693 | 695.81 | -901.49 | Upgrade
|
| Income Tax Expense | 662.89 | 639.66 | 550.47 | 312.58 | 171.33 | Upgrade
|
| Earnings From Continuing Operations | 5,367 | 4,157 | 2,143 | 383.23 | -1,073 | Upgrade
|
| Minority Interest in Earnings | 8.3 | 4.83 | -1.04 | -3.12 | -0.69 | Upgrade
|
| Net Income | 5,375 | 4,162 | 2,142 | 380.11 | -1,074 | Upgrade
|
| Net Income to Common | 5,375 | 4,162 | 2,142 | 380.11 | -1,074 | Upgrade
|
| Net Income Growth | 29.16% | 94.31% | 463.49% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 3,163 | 3,143 | 3,124 | 3,107 | 3,095 | Upgrade
|
| Shares Outstanding (Diluted) | 3,196 | 3,160 | 3,164 | 3,144 | 3,095 | Upgrade
|
| Shares Change (YoY) | 1.14% | -0.12% | 0.62% | 1.60% | 40.13% | Upgrade
|
| EPS (Basic) | 1.70 | 1.32 | 0.69 | 0.12 | -0.35 | Upgrade
|
| EPS (Diluted) | 1.68 | 1.32 | 0.68 | 0.12 | -0.35 | Upgrade
|
| EPS Growth | 27.27% | 94.12% | 466.67% | - | - | Upgrade
|
| Free Cash Flow | 10,174 | 4,294 | 4,544 | 5,865 | 2,929 | Upgrade
|
| Free Cash Flow Per Share | 3.18 | 1.36 | 1.44 | 1.86 | 0.95 | Upgrade
|
| Gross Margin | 24.78% | 22.88% | 22.17% | 21.16% | 23.46% | Upgrade
|
| Operating Margin | 5.17% | 2.00% | 1.18% | -0.31% | -4.58% | Upgrade
|
| Profit Margin | 7.32% | 7.16% | 4.00% | 0.81% | -3.50% | Upgrade
|
| Free Cash Flow Margin | 13.85% | 7.38% | 8.49% | 12.55% | 9.54% | Upgrade
|
| EBITDA | 4,078 | 1,315 | 794.92 | -60.93 | -1,372 | Upgrade
|
| EBITDA Margin | 5.55% | 2.26% | 1.49% | -0.13% | -4.47% | Upgrade
|
| D&A For EBITDA | 279.99 | 151.95 | 164.07 | 84.19 | 32.41 | Upgrade
|
| EBIT | 3,798 | 1,163 | 630.85 | -145.12 | -1,404 | Upgrade
|
| EBIT Margin | 5.17% | 2.00% | 1.18% | -0.31% | -4.58% | Upgrade
|
| Effective Tax Rate | 10.99% | 13.34% | 20.44% | 44.92% | - | Upgrade
|
| Advertising Expenses | 1,934 | 1,564 | 1,305 | 922.22 | 1,290 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.